MAXIMIZING PHARMACEUTICAL RESEARCH BY COLLABORATION

Novartis the Swiss-based multinational pharmaceutical company, is in t he forefront of research into new therapeutic strategies. Like other m ultinationals, it finds that the most effective way of increasing the size and breadth of its research effort is to form alliances with exte rnal academic research groups and with smaller entrepreneurial biotech nology companies.